pain sleep quality, activity
Conditions
Interventions
Group 1: cannabidiol (2x 30mg daily) for 14 days
Group 2: control
Sponsors
Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin, Abteilung 2 Molekulare und zelluläre Sportmedizin - Zentrum für präventive Doping Forschung
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: healthy male and females between 40-65 with chronic, non specific pain
Exclusion criteria
Exclusion criteria: People under 40 years of age People over 65 years of age People with acute and chronic injuries or illnesses (no medication or rehabilitation during the entire intervention period)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammation: - TNF-alpha - IL-6 - blood count - blood lipid levels Schlaf: - quantity - quality pain Measurement time points: T0: before intervention, T1: after intervention (after 14 days). | — |
Secondary
| Measure | Time frame |
|---|---|
| no secondary outcomes | — |
Countries
Germany
Contacts
Public ContactEduard Isenmann
DSHS Köln, Kreislaufforschung und Sportmedizin, Abt.2
Outcome results
None listed